tiprankstipranks
Novavax’s COVID-19 vaccine issued Emergency Use update by WHO
The Fly

Novavax’s COVID-19 vaccine issued Emergency Use update by WHO

Novavax announced that the World Health Organization – WHO – has issued an updated Emergency Use Listing for Nuvaxovid COVID-19 vaccine for active immunization to prevent COVID-19 caused by SARS-CoV-2 as a primary series of two doses in adolescents aged 12 through 17 and as a booster in adults aged 18 and older.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on NVAX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles